Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Physicians who Treat ADHD (EU)(?)

Council Members in this Study Group: 43

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
False economy by companies | 08-27-2008
Analysis of: Healthways' Guidance Not So Healthy | www.forbes.com
Author: GLG Expert Contributor

Healthways is currently struggling, but hopfully this will only be a temporary local difficulty. In the long run Healthways provides a good service

Not too surprising a result | 08-18-2008
Author: GLG Expert Contributor

You can only open up an artery so far. Whether you achieve this with drugs, or a mechanical device doesn't seem to matter as long as the blood gets flowing again.

Schizophrenia treatment options target glutamate | 01-10-2008
Analysis of: Pfizer, Taisho sign schizophrenia deal | uk.biz.yahoo.com
Author: GLG Expert Contributor

A big push forward is granted for treatment ofschizophrenia by an agreement between Pfizer Inc. and Taisho Pharmaceutical Co., Ltd . The research and development  of the metabotropic glutamate receptor (mGluR)  agonist drug (TS-032) is supported . This is good...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Government/Military Hospital or Clinic
  • Non-Academic Community Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Academic Institution*
  • Other Freestanding Healthcare Facility

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Professor
  • Physician - Department Chair
  • Physician - Division Head
  • Owner
  • Partner

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-03T13:45:45.387